Pennsylvania Code & Bulletin
COMMONWEALTH OF PENNSYLVANIA

• No statutes or acts will be found at this website.

The Pennsylvania Code website reflects the Pennsylvania Code changes effective through 53 Pa.B. 8238 (December 30, 2023).

49 Pa. Code § 27.502. Definitions.

§ 27.502. Definitions.

 The following words and terms, when used in § §  27.501 and 27.503—27.506, have the following meanings, unless the context clearly indicates otherwise:

   Cancer drug—A prescription drug used to treat:

     (i)   Cancer or its side effects.

     (ii)   The side effects of a prescription drug used to treat cancer or its side effects.

   Original unopened, sealed and tamper-evident unit dose packaging—Single unit dose packaging of a drug product from a manufacturer or a repackager registered with the Federal Food and Drug Administration, or from a licensed Pennsylvania pharmacy, that has been visually inspected by a licensed pharmacist employed by or under contract with the participating pharmacy who has determined that the packaging appears to be unbreached and undamaged, and includes oral medications, injectables, topicals and aerosols.

Authority

   The provisions of this §  27.502 issued under 6(k)(9) of the Pharmacy Act (63 P.S. §  390-6(k)(9)); and sections 3 and 7 of the Cancer Drug Repository Program Act (62 P.S. § §  2923 and 2927).

Source

   The provisions of this §  27.502 adopted November 27, 2013, effective November 30, 2013, 43 Pa.B. 7011.

Cross References

   This section cited in 49 Pa. Code §  27.501 (relating to purpose).



No part of the information on this site may be reproduced for profit or sold for profit.


This material has been drawn directly from the official Pennsylvania Code full text database. Due to the limitations of HTML or differences in display capabilities of different browsers, this version may differ slightly from the official printed version.